MEDIPURE SCANDINAVIA A/S: Financial statements 2017
CVR: 13275149
Source: annual report 2017, Danish Business Authority
01/07/2016 – 30/06/2017
MEDIPURE SCANDINAVIA A/S (CVR 13275149) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 268,939 and a net result of DKK 158,230 compared with DKK 90,323 the year before. That is an increase of 201.6% compared with the year before. Equity in the 2017 report amounted to DKK 1,753,986. The solvency ratio was 73.6%.
- Gross Profit
- DKK 268,939
- Profit/Loss
- DKK 158,230
- Equity
- DKK 1,753,986
- Total Assets
- DKK 2,383,690
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 269K | 158K | 1.8M | - |
| 2016 | - | 89K | 90K | 1.6M | - |
| 2015 | - | 95K | 170K | 1.5M | - |
| 2014 | - | 582K | 592K | 1.9M | - |
| 2013 | - | 247K | 167K | 1.3M | - |
Official annual report
Keep an eye on MEDIPURE SCANDINAVIA A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAbout MEDIPURE SCANDINAVIA A/S
MEDIPURE SCANDINAVIA A/S was a Danish company of the type Aktieselskab based in Risskov, founded in 1989. The company has been dissolved on 12 November 2025. The company was registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named BAXA INTERNATIONAL ApS and ASX 14709 ApS. The company has 1 employee (2009). In 2024, the company reported a gross profit of DKK -24,760 and a net result of DKK -4,255 compared with DKK -5,675 the year before. Equity in the 2024 report amounted to DKK 789,098.
